dianhydro-3,4-diacetylgalactitol has been researched along with dianhydrogalactitol in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (68.75) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afra, D; Eckhardt, S; Kerpel-Fronius, S; Kocsis, B; Szinai, I | 1 |
| Gál, F; Institóris, E; Otvös, L; Szikla, K | 1 |
| Csetényi, J; Erdélyi-Tóth, V; Kanyár, B; Kerpel-Fronius, S; Kovács, P; Somfai-Relle, S; Ujj, G | 1 |
| Eckhardt, S; Erdélyi-Tóth, V; Kanyár, B; Kerpel-Fronius, S | 1 |
| Erdélyi-Tóth, V; Gyergyay, F; Hindy, I; Kanyár, B; Kerpel-Fronius, S; Kovács, P; Mechl, Z; Nekulová, M; Somfai-Relle, S; Ujj, G | 1 |
| Bence, J; Gáti, E; Somfai-Relle, S | 1 |
| Kralovánszky, J; Prajda, N | 1 |
| Grönroos, M; Kangas, L; Mäenpää, J; Paul, R; Vanharanta, R | 1 |
| Elekes, I; Gorbacheva, LB; Otvös, L; Sokolova, IS | 2 |
| Czirják, F; Dávid, A; Kaszáné, TE; Stampf, G | 1 |
| Gáti, E; Holczinger, L; Institoris, E; Somfai-Relle, S; Turi, G | 1 |
| Liu, CX; Pan, QC; Xu, H; Yang, JN | 1 |
| Liu, JY; Liu, XL; Qin, Y; Xu, H; Yang, JN | 1 |
| Cao, LZ; Lai, XJ; Lan, XW; Liao, ZH; Zhou, SF; Zhou, Y | 1 |
| Guo, W; Li, M; Lian Yan, X; Rong Cui, J; Xu, B; Zhang, XY; Zhou, Y | 1 |
16 other study(ies) available for dianhydro-3,4-diacetylgalactitol and dianhydrogalactitol
| Article | Year |
|---|---|
Combined treatment of anaplastic astrocytoma (grade 3-4) with diacetyl-dianhydro-galactitol (DADAG).
Topics: Adult; Aged; Antineoplastic Agents; Autoradiography; Brain Neoplasms; Combined Modality Therapy; Dianhydrogalactitol; Drug Evaluation; Female; Glioma; Humans; Male; Middle Aged; Sugar Alcohols | 1990 |
Absence of cross-resistance between two alkylating agents: BCNU vs bifunctional galactitol.
Topics: Alkylating Agents; Animals; Antineoplastic Agents; Carmustine; Cross-Linking Reagents; Dianhydrogalactitol; DNA, Neoplasm; Dose-Response Relationship, Drug; Drug Resistance; Drug Screening Assays, Antitumor; Leukemia L1210; Mice; Sugar Alcohols | 1989 |
The role of comparative pharmacokinetics in the planning of human dose escalation: the experience with diacetyldianhydrogalactitol.
Topics: Algorithms; Animals; Dianhydrogalactitol; Female; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Inbred CBA; Rats; Rats, Inbred Strains; Sugar Alcohols | 1988 |
Pharmacokinetic study in a phase I trial with an alkylating agent, diacetyldianhydrogalactitol (DADAG).
Topics: Adult; Alkylating Agents; Antineoplastic Agents; Dianhydrogalactitol; Dose-Response Relationship, Drug; Drug Evaluation; Humans; Kinetics; Metabolic Clearance Rate; Middle Aged; Prednisolone; Protein Binding; Sugar Alcohols | 1986 |
Relation between dose, plasma concentration and toxicity in a phase I trial using high dose intermittent administration of an alkylating agent, diacetyldianhydrogalactitol (DADAG).
Topics: Adult; Aged; Antimetabolites; Antineoplastic Agents; Dianhydrogalactitol; Dose-Response Relationship, Drug; Drug Evaluation; Female; Hematopoietic Stem Cells; Humans; Leukocyte Count; Male; Middle Aged; Platelet Count; Sugar Alcohols; Vomiting | 1986 |
Development and some characteristics of a P388 leukemia strain resistant to 1, 2:5, 6-dianhydrogalactitol.
Topics: Animals; Cell Count; Cell Survival; Cyclophosphamide; Dianhydrogalactitol; Drug Resistance; Female; Karyotyping; Leukemia P388; Leukemia, Experimental; Male; Mechlorethamine; Mice; Sugar Alcohols | 1986 |
Biochemical changes of intestinal epithelial cells induced by cytostatic agents in rats.
Topics: Animals; Antineoplastic Agents; Dianhydrogalactitol; Dose-Response Relationship, Drug; Epithelium; Gastrointestinal Diseases; Intestinal Mucosa; Male; Rats; Sugar Alcohols | 1985 |
Steroid receptors and response of ovarian cancer to cytostatic drugs in vitro.
Topics: Adult; Aged; Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Survival; Cells, Cultured; Cisplatin; Cystadenocarcinoma; Dianhydrogalactitol; Doxorubicin; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Middle Aged; Ovarian Neoplasms; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen | 1984 |
[Effect of 1,2:5,6-dianhydrogalactitol and 1,2:5,6-dianhydro-3,4-diacetylgalactitol on DNA synthesis in the cells of melanoma B16, bone marrow, small intestine epithelium, spleen and liver of mice].
Topics: Animals; Antineoplastic Agents; Bone Marrow; Dianhydrogalactitol; DNA; DNA, Neoplasm; Epithelium; Intestine, Small; Liver; Melanoma; Mice; Mice, Inbred C57BL; Mice, Inbred CBA; Spleen; Sugar Alcohols; Time Factors | 1984 |
Damages of DNA synthesis in normal and tumor cells with sugar alcohol derivatives.
Topics: Animals; Antineoplastic Agents; Bone Marrow; Cell Line; Dianhydrogalactitol; DNA; Injections, Intraperitoneal; Melanoma; Mice; Mice, Inbred Strains; Mucous Membrane; Spleen; Sugar Alcohols; Thymidine; Time Factors | 1984 |
[Drug formulation of a cytostatic compound and testing of the parenteral preparation].
Topics: Dianhydrogalactitol; Freezing; Humans; Infusions, Parenteral; Sugar Alcohols | 1982 |
Complex evaluation of the effect of some cytostatic hexitol derivatives.
Topics: Animals; Antineoplastic Agents; Dianhydrogalactitol; Drug Evaluation, Preclinical; Mice; Mitolactol; Neoplasms, Experimental; Sugar Alcohols | 1980 |
Caspases promoted DADAG-induced apoptosis in human leukemia HL-60 cells.
Topics: Apoptosis; Caspase 3; Caspases; Cell Division; Dianhydrogalactitol; HL-60 Cells; Humans; Leukemia | 2002 |
[Apoptosis induced by diacetyldianhydrogalactitol and its mechanism in HL-60 leukemia cells].
Topics: Antineoplastic Agents; Apoptosis; bcl-X Protein; Caspase 3; Caspases; Cell Division; Dianhydrogalactitol; HL-60 Cells; Humans; Proto-Oncogene Proteins c-bcl-2 | 2002 |
[Apoptosis of hepatocarcinoma cell line HLE induced by the combination of wild type P53 gene and 1,2:5,6-dianhydro-3,4-diacetylgalactitol].
Topics: Antineoplastic Agents, Alkylating; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Dianhydrogalactitol; Genes, p53; Humans; Liver Neoplasms; Transfection | 2004 |
Anticancer activity and mechanisms of diacetyldianhydrogalactitol on hepatoma QGY-7703 cells.
Topics: Animals; Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Dianhydrogalactitol; Humans; Liver Neoplasms; Liver Neoplasms, Experimental; Mice; Mice, Nude; Up-Regulation; Xenograft Model Antitumor Assays | 2009 |